Boston Children's Hospital Launches Pediatric Medical Device Challenge | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Boston Children's Hospital Launches Pediatric Medical Device Challenge

September 11, 2017
by Heather Landi
| Reprints

The Innovation and Digital Health Accelerator (IDHA) at Boston Children’s Hospital and the Boston Pediatric Device Consortium (BPDC) announced a call for applications for the Boston Pediatric Device Strategic Partner Challenge to advance the development of novel pediatric medical device innovations.

The deadline for submissions is 11:59 p.m. ET on October 13, 2017. The national challenge will award up to $250,000 in grants and access to innovators to advance technologies that bridge gaps in pediatric treatment and care.

Challenge winners will receive a combination of up to $50,000 in funding per grant award and/or mentorship opportunities. Challenge co-hosts BPDC and IDHA have joined with strategic partners – Boston Scientific, CryoLife, Edwards Lifesciences, Health Advances, Johnson & Johnson Innovation, Smithwise and Ximedica – to provide strategic support for challenge winners focused on accelerating their paths to commercialization. Mentorship may include product manufacturing support, business plan development and partnerships with industry leaders.

“Innovation in medical devices with the potential to improve the health of children and adolescents continues to lag in comparison to those for adults,” Pedro del Nido, M.D., leader of the Boston Pediatric Device Consortium and Chief of Cardiac Surgery at Boston Children’s Hospital, said in a statement. “With our partners in the Boston Pediatric Device Strategic Partner Challenge and our ongoing efforts, we are committed to finding new ways to provide the resources, mentorship and strategic advising to innovators that can advance technology development and bridge gaps in pediatric care.”

Applications are sought for medical devices that serve the pediatric population. Technologies are accepted at any stage of development, with specific interest in five focus areas: asthma, obesity, sepsis, cardiovascular/endovascular and general pediatrics.

The Challenge is funded in part by the FDA Office of Orphan Products Development through a grant to the Boston Pediatric Device Consortium.

Those interested in participating in the Challenge who are located in the greater Boston metropolitan area are invited to attend an in-person Challenge kickoff event on Tuesday, September 19 from 4:00-6:00 p.m. ET at Hatch Fenway at Pulse@MassChallenge HQ, 401 Park Drive, 8th Floor, Boston, MA 02215. Registration is requested by Friday, September 15 at https://goo.gl/forms/YWKfL2ODIEENH8LW2.

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Blockchain Company Hashed Health Gets New Partner

ODH, Inc., a New Jersey-based health technology company, has joined with blockchain innovation consortium Hashed Health.

NCQA Approved by Government as ONC-Authorized Testing Lab

The National Committee for Quality Assurance (NCQA) has announced that its eMeasure testing laboratory is now approved by the Office of the National Coordinator for Health Information Technology (ONC).

Survey: Infrastructure, Interoperability Key Barriers to Global HIT Development

A new survey report from Black Book Research on global healthcare IT adoption and records systems connectivity finds nations in various phases of regional electronic health record (EHR) adoption. The survey results also reveal rapidly advancing opportunities for U.S.-based and local technology vendors.

Penn Medicine Opens Up Telehealth Hub

Philadelphia-based Penn Medicine has opened its Center for Connected Care to centralize the health system’s telemedicine activities.

Roche to Pay $1.9B for Flatiron Health

Switzerland-based pharmaceutical company Roche has agreed to pay $1.9 billion to buy New York-based Flatiron Health Inc., which has both an oncology EHR and data analytics platform.

Financial Exec Survey: Interoperability Key Obstacle to Value-Based Payment Models

Momentum continues to grow for value-based care as nearly three-quarters of healthcare executives report their organizations have achieved positive financial results from value-based payment programs, to date, according to a new study from the Healthcare Financial Management Association (HFMA).